Skip to content

UROSENS

Active
Private limited companyfounded 20241 yr activeDefacqzstraat 134, 1060 Sint-Gillis (bij-Brussel), BelgiumKBO/BCE: BE 1014.470.738
Summary

The computed 12-month bankruptcy probability of UROSENS is 2.6% (moderate). The 2025 annual accounts show equity of €125,012 and a net result of €120,012. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability100
Solvency93
Growth-
Track record67
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days only on tighter terms
Liquidity ample (current ratio 2.99; short-term debt: 32% and cash: 78.6% of total assets), and 32% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
68%
Return on assets
65.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
14 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

UROSENS was incorporated on 1 October 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€125,012
Total assets
€183,946
Net result
€120,012
Working capital
€117,527

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €183,946
Fixed assets €7,485
Current assets €176,461
Equity and liabilities €183,946
Equity €125,012
Debt €58,934
Debt finances 32.0% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€171,205
Cash flow
€120,533
Current ratio
2.99
Debt to equity
0.47
ROE
96.0%
ROA
65.2%
Interest coverage
1534.10
Debt ≤ 1 year
€58,934
Income taxes
€50,561
Staff costs
€1,671

Peer companies

Historical observation

Of the 11,279 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 2.6% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,279 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 36 lines
Balance sheet Code2025
Assets
Total assets20/58€183,946
Fixed assets21/28€7,485
Tangible fixed assets22/27€7,485
Plant, machinery and equipment23€6,679
Furniture and vehicles24€806
Current assets29/58€176,461
Cash at bank and in hand54/58€144,549
Deferred charges and accrued income490/1€31,912
Equity and liabilities
Total equity and liabilities10/49€183,946
Equity10/15€125,012
Contributions10/11€5,000
Reserves13€120,012
Distributable reserves133€120,012
Amounts payable17/49€58,934
Amounts payable within one year42/48€58,934
Trade debts44€1,809
Suppliers440/4€1,809
Taxes, remuneration and social security45€52,230
Taxes450/3€52,230
Other amounts payable47/48€4,895
Income statement Code2025
Remuneration, social security and pensions62€1,671
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€520
Other operating charges640/8€1,501
Gross operating margin9900€174,377
Operating profit (loss)9901€170,685
Financial income75/76B€0
Recurring financial income75€0
Financial charges65/66B€112
Recurring financial charges65€112
Profit (loss) for the period before taxes9903€170,573
Income taxes67/77€50,561
Profit (loss) for the period9904€120,012
Profit (loss) for the period to be appropriated9905€120,012
Appropriation of the result
Profit (loss) to be appropriated9906€120,012
Transfer to equity691/2€120,012
To other reserves6921€120,012

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Remuneration, social security and pensions62€1,671
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€520
Other operating charges640/8€1,501
Gross operating margin9900€174,377
Operating profit (loss)9901€170,685
Financial income75/76B€0
Recurring financial income75€0
Financial charges65/66B€112
Recurring financial charges65€112
Profit (loss) for the period before taxes9903€170,573
Income taxes67/77€50,561
Profit (loss) for the period9904€120,012
Profit (loss) for the period to be appropriated9905€120,012
Line2025
Assets
Total assets20/58€183,946
Fixed assets21/28€7,485
Tangible fixed assets22/27€7,485
Plant, machinery and equipment23€6,679
Furniture and vehicles24€806
Current assets29/58€176,461
Cash at bank and in hand54/58€144,549
Deferred charges and accrued income490/1€31,912
Equity and liabilities
Total equity and liabilities10/49€183,946
Equity10/15€125,012
Contributions10/11€5,000
Reserves13€120,012
Distributable reserves133€120,012
Amounts payable17/49€58,934
Amounts payable within one year42/48€58,934
Trade debts44€1,809
Suppliers440/4€1,809
Taxes, remuneration and social security45€52,230
Taxes450/3€52,230
Other amounts payable47/48€4,895
Line2025
Profit (loss) for the period9904€120,012
+ Depreciation and write-downs630€520
Operating cash flow (approximation)€120,533

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
17-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Gillis (bij-Brussel) · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
207 m²
Building footprint
138 m²
Volume, LiDAR
2,427 m³
Parcel 21013B0354/00P005, Brussels · tallest building 22.1 m, ±6 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
UROSENS
Defacqzstraat 134, 1060 Sint-Gillis (bij-Brussel)Specialist medical practice
since 20242.372.124.310
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21013B0354/00P005 Brussels 207 m² 1 · 138 m² 22.1 m · 6 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded01-10-2024
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1014470738
Also 9925:BE1014470738
Registered 09-04-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.